cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.23931603
title: Supplementary Material for: Assessment of the needs of nephrology divisions to implement return of clinically significant research genetic results: a survey of Nephrotic Syndrome Study Network (NEPTUNE) investigators

description: Introduction: There is an increasing need to return genetic testing results to patients with kidney disease who first were genotyped on a research basis. Operationalizing this process in nephrology clinics is challenged by a limited number of genetic providers with whom to partner and a general lack of support services for all clinicians. Methods: We administered a survey in March 2022 to assess the current ability and ongoing needs of nephrology divisions to return clinically significant research genetic results to patients and to implement clinical genetic testing. This survey was distributed to institutions within the Nephrotic Syndrome Study Network (NEPTUNE) as part of the planning process for return of research genetic results to participants with pathogenic variants in Mendelian nephrotic syndrome genes. Results: 27 of 28 sites (96%) completed the survey. 59% (n= 16) of sites said they could handle return of research genetic results independently, with the rest expressing hesitation about the volume and complexity of patients and the limited resources and access to genetics services. 81% (n=22) of these institutions did have a genetics clinic and 26% (n=7) have a nephrology genetics clinic. However, 70% (n= 10) of these clinics have a waiting time over one month. 89% of divisions (n=24) are conducting genetic testing and 96% of those (n=23) use a kidney multi-gene panel. In 46% of divisions (n=11), nephrologists are handling logistics of obtaining genetic testing samples themselves. Conclusion: We identified specific areas of support needed for return of clinically significant genetic results from research studies. While the surveyed nephrologists are conducting genetic testing, there are limitations in the support services available. This survey will help guide other research studies that wish to return genetic results to participants and also highlights the need for increasing support to effectively operationalize genetic testing in nephrology clinics.
DOI: 10.17617/4.dl
title: The role of structural order in heterogeneous ice nucleation

description: Sosso, G. C., Sudera, P., Backes, A. T., Whale, T. F., Froehlich-Nowoisky, J., Bonn, M., et al. (2022). The role of structural order in heterogeneous ice nucleation. Chemical Science. doi:10.1039/d1sc06338c.
DOI: 10.6084/m9.figshare.23931621
title: Supplementary Material for: Identification and validation of an aging-associated circRNA-miRNA-mRNA network in neovascular age-related macular degeneration

description: Introduction: Neovascular age-related macular degeneration (NVAMD) is a leading cause of severe vision impairment in the elderly. Aging is one of the most pivotal underlying molecular mechanisms of NVAMD. Methods: In this study, we identified the potential aging-related genes involved in NVAMD. Considering that non-coding RNAs are vital regulators of NVAMD progression, we explored and constructed an aging-originated circRNA-miRNA-mRNA network of NVAMD. Differential expression of 23 aging-associated genes was identified based on sequencing data and the Human Aging Genomic Resources tool at a threshold of P &lt;0.05, and log2|fold change| &gt; 1. Results: We screened 12 microRNAs (miRNAs) using public datasets and the miRNet database. A total of 13 circRNAs were subsequently mined using the StarBase tool. Merging these 13 circRNAs, 12 miRNAs, and 15 genes together, we obtained 281 pairs of circRNA-miRNA and 30 pairs of miRNA-mRNA. Conclusion: We created an aging-related circRNA-miRNA-mRNA network, which could be a promising target for future AMD treatments.
DOI: 10.6084/m9.figshare.23931621.v1
title: Supplementary Material for: Identification and validation of an aging-associated circRNA-miRNA-mRNA network in neovascular age-related macular degeneration

description: Introduction: Neovascular age-related macular degeneration (NVAMD) is a leading cause of severe vision impairment in the elderly. Aging is one of the most pivotal underlying molecular mechanisms of NVAMD. Methods: In this study, we identified the potential aging-related genes involved in NVAMD. Considering that non-coding RNAs are vital regulators of NVAMD progression, we explored and constructed an aging-originated circRNA-miRNA-mRNA network of NVAMD. Differential expression of 23 aging-associated genes was identified based on sequencing data and the Human Aging Genomic Resources tool at a threshold of P &lt;0.05, and log2|fold change| &gt; 1. Results: We screened 12 microRNAs (miRNAs) using public datasets and the miRNet database. A total of 13 circRNAs were subsequently mined using the StarBase tool. Merging these 13 circRNAs, 12 miRNAs, and 15 genes together, we obtained 281 pairs of circRNA-miRNA and 30 pairs of miRNA-mRNA. Conclusion: We created an aging-related circRNA-miRNA-mRNA network, which could be a promising target for future AMD treatments.
DOI: 10.5517/ccxr6pj
title: CCDC 856458: Experimental Crystal Structure Determination

description: Related Article: S.E.Nefedov, E.V.Kushan, M.A.Yakovleva, D.G.Chikhichin, V.A.Kotseruba, O.A.Levchenko, G.L.Kamalov|2012|Koord.Khim.|38|233|
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.23931627
title: Supplementary Material for: Financial advisers’ and key informants’ perspectives on the Australian industry-led Moratorium on Genetic Tests in Life Insurance

description: Introduction: Genetic discrimination (GD) in the context of life insurance is a perennial concern in Australia and internationally. To address such concerns in Australia, an industry self-regulated Moratorium on Genetic Tests in Life Insurance was introduced in 2019 to restrict life insurers from using genetic test results in underwriting for policies under certain limits. Financial advisers (FAs) are sometimes engaged by clients to provide financial advice and assist them to apply for life insurance. They are therefore well-placed to comment on GD and the operation of the Moratorium. Despite this, the financial advising sector in Australia have yet to be studied empirically with regards to GD and the Moratorium. This study aims to capture this perspective by reporting on interviews with the financial advising sector. Methods: Ten semi-structured qualitative interviews were conducted with FAs and key informants and analysed using thematic analysis. Discussion/ conclusion(s): Participants’ level of awareness and understanding of the Moratorium varied. Participants reported mixed views on the Moratorium’s effectiveness and how it operates in practice, and perceived industry compliance. Participants also provided reflections on Australia’s current approach to regulating GD, with most participants supporting the concept of industry self-regulation but identifying a need for this to be supplemented with external oversight and meaningful recourse mechanisms for consumers. Our results suggest that there is scope to increase FAs’ awareness of GD, and that further research, consultation and policy consideration are required to identify an optimal regulatory response to GD in Australia
DOI: 10.5281/zenodo.8238512
title: consumer risk perception toward pesticide stained tomatoes in Uganda

description: A data set for measuring consumer risk perception towards pesticide-stained tomatoes in Uganda (sample 4 major regions in Uganda)
description: pesticide pre-exposure in diet
DOI: 10.5281/zenodo.8238511
title: consumer risk perception toward pesticide stained tomatoes in Uganda

description: A data set for measuring consumer risk perception towards pesticide-stained tomatoes in Uganda (sample 4 major regions in Uganda)
description: pesticide pre-exposure in diet
DOI: 10.5281/zenodo.8227494
title: TW Hya STIS Spectral Imaging

description: 2-D spectral image from HST PID 11607 (PI: T. Bethell)
DOI: 10.5281/zenodo.8238490
title: TW Hya STIS Spectral Imaging

description: 2-D spectral image from HST PID 11607 (PI: T. Bethell)
DOI: 10.5281/zenodo.8227493
title: TW Hya STIS Spectral Imaging

description: 2-D spectral image from HST PID 11607 (PI: T. Bethell)
DOI: 10.6084/m9.figshare.23276315
title: Supplementary Material for: Individualized homeopathic medicines in the treatment of psoriasis vulgaris: Double-blind, randomized, placebo-controlled trial

description: Introduction: Psoriasis is a chronic inflammatory skin disorder, affecting the trunk and extensor surfaces of limbs and scalp predominantly. Worldwide prevalence ranges between 0.1 and 11.4%, and in India between 0.4 and 2.8%; this creates a serious health burden. Psoriasis remains a frequently encountered condition in homeopathy practice, but there is a dearth of conclusive efficacy data supporting its use. Methods: This 6-month, double-blind, randomized trial was conducted on 51 patients suffering from psoriasis at the National Institute of Homoeopathy, India. Patients were randomized to receive either individualized homeopathic medicines (IHMs; n = 25) in LM potencies or identical-looking placebos (n=26). Psoriasis area and severity index (PASI; primary), psoriasis disability index (PDI), and dermatological life quality index (DLQI; secondary) were measured at baseline, and every 2 months, up to 6 months. The intention-to-treat sample was analyzed using a two-way repeated measure analysis of variance. Results: Although intra-group changes were significant in both groups in the outcome measures, improvements were significantly higher in the IHMs group than in placebos in PASI scores after 6 months of intervention (F1, 49 = 10.448, P = 0.002). DLQI daily activity subscale scores also yielded similar significant results favoring IHMs against placebos after 6 months (F1, 49 = 5.480, P = 0.023). Improvement in PDI total (F1, 49 = 0.063, P = 0.803), DLQI total (F1, 49 = 1.371, P = 0.247), and all remaining subscales were higher in the IHMs group than placebos after 6 months, but non-significant statistically. Calcarea carbonica, Mercurius solubilis, Arsenicum album, and Petroleum were the most frequently prescribed medicines. Conclusions: IHMs exhibited better results than placebos in the treatment of psoriasis. Further research is warranted. Trial registration: CTRI/2019/11/021917; UTN: U1111-1242-8843
DOI: 10.5281/zenodo.8043220
title: Whole-genome capture and sequencing of Francisella tularensis directly from clinical samples

description: This dataset comprises: <strong>1. The design of RNA oligonucleotide baits for Agilent Technologies’ SureSelect target enrichment - <strong>54756 RNA oligonucleotide "baits" (120 bp each) </strong></strong>designed to perform <strong>whole-genome capture and sequencing of </strong><strong>Francisella tularensis<strong> directly from clinical samples</strong></strong> (DNA) using Agilent Technologies’ SureSelect target enrichment system following the Illumina paired-end multiplexed sequencing library protocol. RNA oligonucleotide “baits” were designed to span the <em>Francisella tularensis </em>chromosome and plasmid, accounting for the genetic variability among publicly available genome sequences. All resulting sequences were BLASTn searched against the Human Genomic + Transcript database to excluded homologous sequences to the human genome. Overall, a total of 54756 RNA probes were generated and this custom bait library was then uploaded to the SureDesign software (https://earray.chem.agilent.com/suredesign) and synthesized by Agilent Technologies. <strong>2. Genome assemblies of 17 Francisella tularensis samples generated in the context of validation and application of SureSelect target enrichment for Whole-genome capture and sequencing of Francisella tularensis directly from clinical samples </strong> File “<strong>Ft_assembly_metadata.xlsx</strong>” contains the genome assembly statistics for each isolate, including European Nucleotide Archive accession numbers. The archive “<strong>Ft_assemblies.zip</strong>” contains all the genome assemblies (.fasta format) of each isolate presented in the metadata file. More details can be found in the following publication: (available soon)
DOI: 10.5281/zenodo.8043219
title: Whole-genome capture and sequencing of Francisella tularensis directly from clinical samples

description: This dataset comprises: <strong>1. The design of RNA oligonucleotide baits for Agilent Technologies’ SureSelect target enrichment - <strong>54756 RNA oligonucleotide "baits" (120 bp each) </strong></strong>designed to perform <strong>whole-genome capture and sequencing of </strong><strong>Francisella tularensis<strong> directly from clinical samples</strong></strong> (DNA) using Agilent Technologies’ SureSelect target enrichment system following the Illumina paired-end multiplexed sequencing library protocol. RNA oligonucleotide “baits” were designed to span the <em>Francisella tularensis </em>chromosome and plasmid, accounting for the genetic variability among publicly available genome sequences. All resulting sequences were BLASTn searched against the Human Genomic + Transcript database to excluded homologous sequences to the human genome. Overall, a total of 54756 RNA probes were generated and this custom bait library was then uploaded to the SureDesign software (https://earray.chem.agilent.com/suredesign) and synthesized by Agilent Technologies. <strong>2. Genome assemblies of 17 Francisella tularensis samples generated in the context of validation and application of SureSelect target enrichment for Whole-genome capture and sequencing of Francisella tularensis directly from clinical samples </strong> File “<strong>Ft_assembly_metadata.xlsx</strong>” contains the genome assembly statistics for each isolate, including European Nucleotide Archive accession numbers. The archive “<strong>Ft_assemblies.zip</strong>” contains all the genome assemblies (.fasta format) of each isolate presented in the metadata file. More details can be found in the following publication: (available soon)
DOI: 10.34740/kaggle/dsv/6286408
title: Egypt Gold Prices | Daily Updated
DOI: 10.6084/m9.figshare.23896836
title: Fig.4(c)

description: Condensation energy for 2D electron gas and our coupled system
DOI: 10.6084/m9.figshare.23896809
title: Fig.3(a,b)

description: Berry curvature for Ls =50,600 A and r=3
DOI: 10.6084/m9.figshare.23896809.v1
title: Fig.3(a,b)

description: Berry curvature for Ls =50,600 A and r=3
DOI: 10.6084/m9.figshare.23896815
title: Fig.3(c,d)

description: Band structure for Ls =50,600 A and r=3
DOI: 10.6084/m9.figshare.23896815.v1
title: Fig.3(c,d)

description: Band structure for Ls =50,600 A and r=3
DOI: 10.6084/m9.figshare.23896824.v1
title: Fig.3(e)

description: Colormap of vF as a function of dielectric constant and Ls
DOI: 10.6084/m9.figshare.23896830
title: Fig.4(a,b)

description: Density distribution in real space on the graphene side (a) and the substrate (b)
DOI: 10.6084/m9.figshare.23896806
title: Fig.2(f)

description: Berry curvature distribution for graphene on CrOCl
DOI: 10.6084/m9.figshare.23896824
title: Fig.3(e)

description: Colormap of vF as a function of dielectric constant and Ls
DOI: 10.6084/m9.figshare.23896830.v1
title: Fig.4(a,b)

description: Density distribution in real space on the graphene side (a) and the substrate (b)
DOI: 10.6084/m9.figshare.23896788
title: Fig.2(b)

description: HF band structure for Ls=50 A and r=1.2 at CNP
DOI: 10.6084/m9.figshare.23896797
title: Fig.2(c)

description: HF band structure for Ls=50 and r=1.2 with slight hole doping
DOI: 10.6084/m9.figshare.23896803.v1
title: Fig.2(e)

description: Thermal gap of graphene on CrOCl as a function of carrier density
DOI: 10.6084/m9.figshare.23896806.v1
title: Fig.2(f)

description: Berry curvature distribution for graphene on CrOCl
DOI: 10.6084/m9.figshare.23896788.v1
title: Fig.2(b)

description: HF band structure for Ls=50 A and r=1.2 at CNP
DOI: 10.6084/m9.figshare.23896797.v1
title: Fig.2(c)

description: HF band structure for Ls=50 and r=1.2 with slight hole doping
DOI: 10.6084/m9.figshare.23896800
title: Fig.2(d)

description: interacting Gap and enhanced vF as a function of density
DOI: 10.6084/m9.figshare.23896782
title: Fig.1(d)

description: Colormap of fine-structure constant as a function of Ls and dielectric constant
DOI: 10.6084/m9.figshare.23896785
title: Fig.2(a)

description: 3D plot of band structure around Dirac point (conduction band and valence band)
DOI: 10.6084/m9.figshare.23896785.v1
title: Fig.2(a)

description: 3D plot of band structure around Dirac point (conduction band and valence band)
DOI: 10.6084/m9.figshare.23896800.v1
title: Fig.2(d)

description: interacting Gap and enhanced vF as a function of density
DOI: 10.6084/m9.figshare.23896803
title: Fig.2(e)

description: Thermal gap of graphene on CrOCl as a function of carrier density
DOI: 10.6084/m9.figshare.23896776
title: Fig.1(c)

description: Non-interacting band structure for Ls=600 A and r=1.2
DOI: 10.6084/m9.figshare.23896782.v1
title: Fig.1(d)

description: Colormap of fine-structure constant as a function of Ls and dielectric constant
DOI: 10.6084/m9.figshare.23807736.v1
title: Flow intermittency affects the nutritional quality of phototrophic biofilms and their capacity to support secondary production

description: This file contains two data sets: the first one with variables normalised by carbon quantity (Qualit_Carbon_2.csv) and the second one with variables expressed per surface unit (Data_surface.csv). The two data sets contain data about biofilms and primary producers.
DOI: 10.6084/m9.figshare.23807736
title: Flow intermittency affects the nutritional quality of phototrophic biofilms and their capacity to support secondary production

description: This file contains two data sets: the first one with variables normalised by carbon quantity (Qualit_Carbon_2.csv) and the second one with variables expressed per surface unit (Data_surface.csv). The two data sets contain data about biofilms and primary producers.
DOI: 10.34943/8bb17f52-0afb-47a0-aa27-7b936a24fe36
title: Cambridge Bay Turbidity Meter Deployed 2023-08-01

description: The WET Labs ECO-NTUS 319 was deployed on 2023-08-01 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Turbidity Meter. Turbidity meters are sensors that detect scattered light from suspended particles in water. The amount of scattered light that reaches the detector is proportional to the turbidity or particle concentration in the water. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.5281/zenodo.8238569
title: domOS Sion Living Lab: Household and Heat Pump Electricity Consumption Data

description: This dataset has been collected in context of the domOS H2020 project (https://www.domos-project.eu/). The dataset includes data about the electricity consumption of 15 single-family residential households all located around Sion (Switzerland), in the OIKEN service area (https://oiken.ch). All the households are equipped with an individual heat pump providing energy for both space heating and domestic hot water. The ongoing data collection began in January 2021 and includes the households’ total electricity consumption provided by the Smart Meter. It also includes the specific consumption of the heat pump and the production of the solar panels (where applicable) provided by dedicated sub-meters.
DOI: 10.5281/zenodo.8238570
title: domOS Sion Living Lab: Household and Heat Pump Electricity Consumption Data

description: This dataset has been collected in context of the domOS H2020 project (https://www.domos-project.eu/). The dataset includes data about the electricity consumption of 15 single-family residential households all located around Sion (Switzerland), in the OIKEN service area (https://oiken.ch). All the households are equipped with an individual heat pump providing energy for both space heating and domestic hot water. The ongoing data collection began in January 2021 and includes the households’ total electricity consumption provided by the Smart Meter. It also includes the specific consumption of the heat pump and the production of the solar panels (where applicable) provided by dedicated sub-meters.
DOI: 10.6084/m9.figshare.23931669
title: test

description: test
DOI: 10.6084/m9.figshare.23931669.v1
title: test

description: test
DOI: 10.25405/data.ncl.23895822
title: Anxiety, suicidality, autistic traits and camouflaging data

description: Data from Phase 1 of Exploring Suicidality, Autistic traits and camouflaging within women with anxiety. 148 participants included in dataset. Includes: demographic information on age, gender, sexuality, ethnicityScores captured: HADS, SPIN, BAPQ, CATQ, INQ-15, ACSS-FAD
DOI: 10.25405/data.ncl.23895822.v1
title: Anxiety, suicidality, autistic traits and camouflaging data

description: Data from Phase 1 of Exploring Suicidality, Autistic traits and camouflaging within women with anxiety. 148 participants included in dataset. Includes: demographic information on age, gender, sexuality, ethnicityScores captured: HADS, SPIN, BAPQ, CATQ, INQ-15, ACSS-FAD
DOI: 10.25403/upresearchdata.23899605
title: Family members caring for mental health care users in the Vhembe district

description: A multi-method design was used to develop a psychoeducational programme to support family members caring for mental health care users in the Vhembe District of Limpopo Province, South Africa. The study adopted a pragmatic approach in three phases, of which Phase 1 of the study used qualitative, explorative, descriptive, and contextual approaches. One-on-one semi-structured individual interviews with the family members were used to collect qualitative data. Braun and Clark's thematic data analysis was employed to analyse the collected qualitative data.
DOI: 10.25403/upresearchdata.23899605.v1
title: Family members caring for mental health care users in the Vhembe district

description: A multi-method design was used to develop a psychoeducational programme to support family members caring for mental health care users in the Vhembe District of Limpopo Province, South Africa. The study adopted a pragmatic approach in three phases, of which Phase 1 of the study used qualitative, explorative, descriptive, and contextual approaches. One-on-one semi-structured individual interviews with the family members were used to collect qualitative data. Braun and Clark's thematic data analysis was employed to analyse the collected qualitative data.
DOI: 10.5281/zenodo.8238630
title: Endo_TS1_G03_PCM_carbon_tetrachloride_v_01_reactant

description: Gaussian 16 (C01) calculation
DOI: 10.5281/zenodo.8238629
title: Endo_TS1_G03_PCM_carbon_tetrachloride_v_01_reactant

description: Gaussian 16 (C01) calculation
DOI: 10.5517/ccdc.csd.cc1pk6gx
title: CCDC 1565669: Experimental Crystal Structure Determination

description: Related Article: Sreejith Shankar, Olga Chovnik, Linda J. W. Shimon, Michal Lahav, and Milko E. van der Boom|2018|Cryst.Growth Des.|18|1967|doi:10.1021/acs.cgd.7b01163
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5281/zenodo.8238634
title: Endo_TS1_G03_PCM_carbon_tetrachloride_v_01

description: Gaussian 16 (C01) calculation
DOI: 10.5281/zenodo.8238633
title: Endo_TS1_G03_PCM_carbon_tetrachloride_v_01

description: Gaussian 16 (C01) calculation